Tag Visualization: Top 50 related tags by occurrence
Regeneron ends four clinical trials of its rolled back Covid-19 antibody – Endpoints News
Added to Collection on: 2022-08-01 20:26:54
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Covid-19 Treatment Medicine Market Growth 2022-2028: Pfizer (Paxlovid), VEKLURY ...
Added to Collection on: 2022-09-04 06:57:16
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Press Release: Dupixent® (dupilumab) Phase 3 Results show - GlobeNewswire
Added to Collection on: 2023-10-22 19:23:08
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
COVID drugs more often given to Medicare patients who least need them, study suggests
Added to Collection on: 2024-01-26 21:57:52
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
New Monoclonal Authorized to Prevent COVID in Immunocompromised People
Added to Collection on: 2024-03-22 22:50:07
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Roche warns 2023 profits will fall on $5 billion COVID sales hit - Yahoo Movies UK
Added to Collection on: 2024-05-03 14:42:05
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Monoclonal Antibody Combination Improves HRQOL in Patients With COVID-19
Added to Collection on: 2024-10-15 14:33:43
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
FDA Revokes EUAs of Four COVID-19 Monoclonal Antibodies | MedPage Today
Added to Collection on: 2024-12-13 23:04:03
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Regeneron settles patent lawsuit over protein for testing COVID-19 treatments - TradingView
Added to Collection on: 2024-12-16 20:34:57
Tags for this article:
Click the tags to see associated articles and topics
View Article Details
Ronapreve - opinion on variation to marketing authorisation - European Medicines Agency
Added to Collection on: 2025-01-31 18:20:56
Tags for this article:
Click the tags to see associated articles and topics
View Article Details